

Publisher: Bentham Science Publishers
E-ISSN: 2212-2710|1|1|9-12
ISSN: 1872-213X
Source: Recent Patents on Inflammation & Allergy Drug Discovery, Vol.1, Iss.1, 2007-02, pp. : 9-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Daclizumab: A Potential Asthma Therapy?
Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 4, Iss. 3, 2010-11 ,pp. :





